Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SVF + PRP
- Development stage
- Unknown
- Lead developer
- Bioheart
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
SVF + PRP is an autologous biological combination therapy developed by Bioheart, Inc. (now U.S. Stem Cell, Inc.) for the treatment of osteoarthritis, particularly of the knee. The therapy consists of a stromal vascular fraction (SVF) isolated from the patient's own adipose tissue via a mini-lipoaspirate procedure, which is then resuspended in autologous platelet-rich plasma (PRP) obtained from peripheral blood. The SVF provides a heterogeneous population of cells, including mesenchymal stem cells (MSCs), while the PRP provides a concentrated source of growth factors. This combination is administered via intra-articular injection to promote tissue regeneration, reduce inflammation, and improve joint function in patients with grade 1 and 2 osteoarthritis.
- Other names
- Intra-articular injection of SVF plus PRPAdipose Derived Stromal Cells and Platelet Rich Plasma
Beyond the preview
Go deeper on SVF + PRP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SVF + PRP.